U.S. Software Stock News

Vera Therapeutics (VERA) drew investor attention after receiving accelerated FDA approval for TRUTAKNA for adult patients with primary IgA nephropathy at risk of disease progression, alongside releasing its latest quarterly financial results. See our latest analysis for Vera Therapeutics. Despite the recent regulatory progress, Vera Therapeutics’ share price has been under pressure, with a 30 day share price return down 27.88% and a year to date share price return down 37.70%. At the same...

Palomar Holdings has delivered a very strong 144.6% return over the past 3 years, yet the stock now screens as overvalued on earnings-based measures and only earns a mixed overall value score. That combination raises the question of whether recent gains already reflect the key positives in the story. The 144.6% 3 year return suggests the market has rerated Palomar Holdings significantly and may now be pricing in optimistic expectations. Expectations for sustained profitable growth can...

With rate hike odds slipping, a softer jobs report and real wages falling behind inflation, the market is rethinking how to price reliable income and resilience. That shift can punish fragile business models and reward those that hold up when growth and policy look unsure. This article explains how that backdrop interacts with our Defensive Dividend and Consumer Staples Stocks screener and highlights 3 stocks that appear positively exposed to the latest Fed and inflation twist. The stocks...

In the past quarter, Ameren Corporation reported Q2 2026 revenue of US$2,092 million, down from US$2,221 million a year earlier, while net income rose to US$314 million and diluted EPS from continuing operations increased to US$1.13. Ameren also reaffirmed its full-year 2026 earnings guidance of US$5.25 to US$5.45 per share, highlighting management’s confidence despite softer top-line results. We’ll now examine how Ameren’s stronger earnings amid lower revenue and reaffirmed 2026 guidance...

Oil markets are back in the spotlight as Operation Economic Fury, tighter U.S. sanctions on Iran and disruption around the Strait of Hormuz squeeze global supply and feed into inflation worries. That mix can punish some stocks and support others, and sitting on the sidelines may mean missing important moves. This article looks at 3 integrated oil and gas producers that are directly exposed to these headlines. The 3 stocks below are just a small sample of the integrated producers on the radar,...

Cooling inflation in major economies is shifting attention back to growth stories. That includes the companies building the chips, software and cloud tools behind ChatGPT and other artificial intelligence systems. As investors weigh how rate paths might affect long term themes, AI stocks from this screener offer focused exposure to that trend. This article walks through three screen picks to help you assess if they fit your portfolio. The three stocks covered below are only a sample from this...

Why CVR Partners’ latest quarter matters for income focused investors CVR Partners (UAN) has drawn fresh attention after reporting second quarter 2026 earnings with higher sales, net income and production, alongside a declared cash distribution of $6.08 per common unit. This combination of strong reported results and a sizable payout puts the focus on how the business is currently generating cash and what that might mean for unitholders who rely on CVR Partners for income. See our latest...

Rollins Inc recently paid a total cash dividend of US$0.18 per share, with the ex-dividend date on August 10, 2026, and payment made on September 10, 2026, extending a dividend track record that dates back to 1985. This long-running and consistently funded dividend program, supported by a moderate payout ratio and strong profitability metrics, highlights management’s focus on returning capital to shareholders in a measured way. Next, we’ll examine how this continued dividend commitment,...

DigitalOcean Holdings (DOCN) is back in focus after reporting Q2 2026 results that paired strong year-over-year revenue growth with modestly lower earnings, while also raising its full year outlook on continued AI driven demand. See our latest analysis for DigitalOcean Holdings. DigitalOcean Holdings’ share price has pulled back recently, with a 1 day share price return of down 6.84% and a 90 day share price return of down 24.07%. However, the year to date share price return of 146.80% and 1...

In early August 2026, Beyond Meat reported second-quarter sales of US$68.83 million, a swing to US$16.4 million in net income from a net loss a year earlier, and guided third-quarter net revenues to approximately US$60 million to US$65 million. This move to profitability, even as first-half sales declined year over year, suggests the company’s cost-cutting and efficiency measures are materially affecting its financial profile. We’ll now examine how this return to quarterly profitability...

Shareholders in Monte Rosa Therapeutics, Inc. ( NASDAQ:GLUE ) may be thrilled to learn that the analysts have just...

Earlier this month, Eaton announced a subcontract with Infleqtion to apply its neutral atom quantum computing hardware and algorithms to power grid contingency analysis, aiming to improve how utilities model equipment failures and prevent cascading outages. This project gives Infleqtion a real-world testbed for its optimization, circuit efficiency and error correction work, directly linking its Sqale platform to critical infrastructure reliability use cases. Next, we’ll examine how this grid...

In August 2026, Equity Bancshares, Inc. (NYSE: EQBK) announced a one-year share repurchase program authorizing the buyback of up to 1,000,000 outstanding common shares. This move highlights management’s willingness to deploy excess capital toward reducing share count, a step that can alter per-share metrics and capital allocation priorities. Next, we’ll examine how this newly authorized 1,000,000-share repurchase program may influence Equity Bancshares’ existing investment narrative and...

Cisco Systems (NasdaqGS:CSCO) is rolling out personalized AI agents across its roughly 90,000 employees as part of a company wide operational shift. The deployment standardizes AI agent infrastructure inside Cisco, with tools aimed at automating day to day decisions and workflows. Cisco is also advancing its Webex AI Agents and upgrading collaboration hardware while retiring older platforms such as Polycom. Recent patent mapping points to a broader push in AI driven collaboration and...

Astrana Health stock has climbed 18.5% over the past year yet remains down about 54.0% over five years, which leaves investors weighing a recent rebound against a longer period of weaker returns and a share price that screens as overvalued on earnings multiples. The question for anyone looking at Astrana Health now is whether the current price already reflects the business progress implied by recent revenue and earnings updates. The share price decline of about 54.0% over five years points...

In the past few days, Raymond James Financial reported Q3 FY26 earnings per share of 3.14, coming in above analyst estimates and underscoring the breadth of its investment banking, asset management, and banking operations. An interesting angle is that this stronger-than-expected profitability arrives as the firm is already emphasizing advisor recruitment, AI investment, and banking growth, potentially reinforcing confidence in its multi-segment business model. Next, we’ll examine how this...

Fifth Third Bancorp recently completed key steps in transitioning Comerica customers to its own products, highlighting no-fee Momentum Checking, earlier access to direct deposits, expanded branch and drive-through services, and enhanced mobile security and money management tools. This comprehensive product and service upgrade positions Fifth Third to deepen relationships with incoming Comerica customers by emphasizing lower fees, greater access to funds, and a more feature-rich digital...

Bob's Discount Furniture stock has gained 17.3% over the past month, while both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading at a premium. The broader valuation checks add to this, suggesting the stock is not a straightforward bargain at today’s price of US$18.35. The 17.3% move over the past month signals that investor expectations have shifted quickly, which can leave less room if sentiment cools. For a retailer like...

First Financial Bankshares (FFIN) recently increased its equity buyback authorization by 2,200,000 shares to a total of 7,200,000 and extended the program through July 31, 2027, drawing fresh attention to the stock. See our latest analysis for First Financial Bankshares. The buyback announcement comes after a period where First Financial Bankshares’ share price has gained 15.92% year to date and 11.15% over 90 days, while its 1 year total shareholder return is 1.77% and the 5 year total...

Earlier this month, Spyre Therapeutics announced the launch of SPY772, a combination of its anti-TL1A and anti-IL-17A/F antibodies in preclinical development, alongside the initiation of SKYLIGHT, a randomized Phase 2 proof-of-concept trial in moderate-to-severe Hidradenitis Suppurativa using background bimekizumab and targeting HiSCR75 at Week 16. This dual-pathway approach in an area of high unmet medical need adds another layer to Spyre’s pipeline ambitions and could reshape how investors...

Blue Owl Capital (NYSE: OWL) announced offerings of US$750 million and US$500 million in senior notes to refinance its existing revolving credit facility. The company intends to use the proceeds to replace short term borrowing with longer term debt, extending its maturity profile. The refinancing is aimed at improving liquidity and providing greater clarity around Blue Owl Capital's capital structure for investors. For more context on how other listed asset managers are funding growth and...

Leonardo DRS (DRS) is back in focus after its SGT STOUT M SHORAD system successfully countered small unmanned aerial threats in a U.S. Government test and the company signed a defense technology partnership with UAE based Space42. See our latest analysis for Leonardo DRS. The latest contract wins and test results come after a strong run in Leonardo DRS’s share price, with a year to date share price return of 28.41% and a three year total shareholder return of 168.12% signaling that momentum...

NVIDIA Corporation recently announced that it has entered into memorandums of understanding with KKR & Co. Inc. and five other major financial institutions to create independent compute financing platforms aiming to mobilize over US$500.00 billion of third-party capital for AI infrastructure across its ecosystem. This move highlights how KKR is being positioned as a core private-capital partner in funding large-scale AI compute projects, an area that could reshape capital allocation in...

Boston Scientific Corporation ( NYSE:BSX ) shareholders (or potential shareholders) will be happy to see that the...